Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy

References

• OrdituraMGaliziaGSforzaVTreatment of gastric cancerWorld J Gastroenterol20142071635164924587643
   PubMed Web of Science ®Google Scholar
• KanterMAIsaacsonNHKnollAMNochomovitzLEThe diagnostic challenge of metastatic linitis plastic. Two cases and a consideration of the problemAm Surg19865295105133019197
   PubMed Web of Science ®Google Scholar
• ParkMSHaHKChoiBSScirrhous gastric carcinoma: endoscopy versus upper gastrointestinal radiographyRadiology2004231242142615128987
   PubMed Web of Science ®Google Scholar
• FurukawaHHiratsukaMIwanagaTExtended surgery – left upper abdominal exenteration plus Appleby’s method – for type 4 gastric carcinomaAnn Surg Oncol1997432092149142381
   PubMed Web of Science ®Google Scholar
• SugaSIwaseHShimadaMNeoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatinIntern Med199635129309369030989
   PubMed Web of Science ®Google Scholar
• TakahashiSKinoshitaTKonishiMPhase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancerGastric Cancer20014419219711846062
   PubMedGoogle Scholar
• KinoshitaTSasakoMSanoTPhase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002)Gastric Cancer2009121374219390930
   PubMed Web of Science ®Google Scholar
• KunisakiCMakinoHKimuraJImpact of S-1 plus cisplatin neoadjuvant chemotherapy on scirrhous gastric cancerOncology201588528128825591954
   PubMed Web of Science ®Google Scholar
• FushidaSOyamaKKinoshitaJIntraperitoneal chemotherapy as a multimodal treatment for gastric cancer patients with peritoneal metastasisJ Cancer Ther20130409615
   Google Scholar
• IshigamiHKitayamaJKaisakiSPhase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasisAnn Oncol2010211677019605503
   PubMed Web of Science ®Google Scholar
• FujiwaraYTakiguchiSNakajimaKIntraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal disseminationJ Surg Oncol20121051384221882194
   PubMed Web of Science ®Google Scholar
• FushidaSKinoshitaJKajiMPhase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosisCancer Chemother Pharmacol20137151265127223423490
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer AssociationJapanese Classification of Gastric Carcinoma - 2nd English EditionGastric Cancer199811102411957040
   PubMedGoogle Scholar
• OtsujiEKuriuYOkamotoKOutcome of surgical treatment for patients with scirrhous carcinoma of the stomachAm J Surg2004188332733215450843
   PubMed Web of Science ®Google Scholar
• MarkmanMIntraperitoneal antineoplastic drug delivery: rationale and resultsLancet Oncol20034527728312732164
   PubMed Web of Science ®Google Scholar
• IshigamiHKitayamaJOtaniKPhase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancerOncology200976531131419299904
   PubMed Web of Science ®Google Scholar
• FushidaSKinoshitaJYagiMDual anticancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasible and farmacokinetic studyOncology Rep200819513051310
   PubMed Web of Science ®Google Scholar
• ShirasakaTNakanoKTakechiTAntitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude ratsCancer Res19965611260226068653704
   PubMed Web of Science ®Google Scholar
• OshimaTYamadaRHatoriSKunisakiCImadaTPharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancerOncol Rep200616236136616820916
   PubMed Web of Science ®Google Scholar
• GlehenOGillyFNArvieuxCPeritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapyAnn Surg Oncol20101792370237720336386
   PubMed Web of Science ®Google Scholar
• YangXJHuangCQSuoTCytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trialAnn Surg Oncol20111861575158121431408
   PubMed Web of Science ®Google Scholar
• MaggeDZenatiMMavanurAAggressive locoregional surgical therapy for gastric peritoneal carcinomatosisAnn Surg Oncol20142151448145524197761
   PubMed Web of Science ®Google Scholar
• TakahashiNKandaMYoshikawaTA randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trialGastric Cancer2018
   Web of Science ®Google Scholar
• YashiroMChungYSNishimuraSInoueTSowaMFibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as “soil” for peritoneal disseminationCancer1996778 Suppl166816758608560
   PubMed Web of Science ®Google Scholar
• GoldfarbYSorskiLBenishMLeviBMelamedRBen-EliyahuSImproving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responsesAnn Surg2011253479881021475023
   PubMed Web of Science ®Google Scholar
• ChouWCChangCLLiuKHTotal gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatmentWorld J Surg Oncol20131128724180462
   PubMed Web of Science ®Google Scholar
• AoyamaTSatoTSegamiKRisk factors for the loss of lean body mass after gastrectomy for gastric cancerAnn Surg Oncol20162361963197026762272
   PubMed Web of Science ®Google Scholar
• FujitaniKYangHKMizusawaJGastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialLancet Oncol201617330931826822397
   PubMed Web of Science ®Google Scholar
• WilkeHMuroKVan CutsemERamucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trialLancet Oncol201415111224123525240821
   PubMed Web of Science ®Google Scholar
• FuchsCSTomasekJYongCJRamucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multi-centre, placebo-controlled, phase 3 trialLancet20143839911313924094768
   PubMed Web of Science ®Google Scholar
• ChauhanVPStylianopoulosTMartinJDNormalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent mannerNat Nanotechnol20127638338822484912
   PubMed Web of Science ®Google Scholar
• BandoHShimodairaHFujitaniKA phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancerEur J Cancer201891869129353164
   PubMed Web of Science ®Google Scholar
• XuJLamouilleSDerynckRTGF-beta-induced epithelial to mesenchymal transitionCell Res200919215617219153598
   PubMed Web of Science ®Google Scholar
• FuyuhiroYYashiroMNodaSUpregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cellsBr J Cancer20111057996100121863023
   PubMed Web of Science ®Google Scholar
• KinoshitaJFushidaSHaradaSLocal angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivinInt J Oncol20093461573158219424575
   PubMed Web of Science ®Google Scholar
• OkazakiMFushidaSHaradaSThe angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancerCancer Lett20143551465325224569
   PubMed Web of Science ®Google Scholar
• SaitoHFushidaSHaradaSImportance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilastGastric Cancer2018211556728540637
   PubMed Web of Science ®Google Scholar